Percutaneous Neuromodulation on the Anterior Pain Knee
Effect of the Ultrasound-guided Percutaneous Neuromodulation on the Anterior Pain Knee: a Pilot Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Seville, Spain, 41010
- University of Seville
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- chronic anterior knee pain >3 months
- older than 18 years-old
Exclusion Criteria:
- Surgical intervention in the intervention area
- Prosthesis or osteosynthesis in the intervention area
- Cardiac or tumoral diseases
- Coagulopathies
- Be under the effects of certain medications
- contraindication characteristic of the puncture
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Group 1: PNM in pain knee
participants in whom PNM will be applied to the femoral nerve of the pain knee
|
an asymmetric rectangular biphasic current (250 microseconds, 10 Hz)
|
|
EXPERIMENTAL: Group 2: PNM in non-pain knee
participants in whom PNM will be applied to the femoral nerve of the non-pain knee
|
an asymmetric rectangular biphasic current (250 microseconds, 10 Hz)
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
visual analog scale (VAS) (0, no pain; 100, maximum pain).
Time Frame: up to 1 week
|
pain
|
up to 1 week
|
|
range joint
Time Frame: up to 1 week
|
goniometer
|
up to 1 week
|
|
VISA-p questionnaire (0, maximum pain; 100, no pain).
Time Frame: up to 1 week
|
Functional pain
|
up to 1 week
|
|
Kujala questionnaire (0, maximum pain; 100, no pain).
Time Frame: up to 1 week
|
Functional pain
|
up to 1 week
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- PNM and knee
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.